Psoriatic Arthritis News

Recently published results showed older adults with arthritis had a lower health-related quality of life, especially among those with at least one other common chronic condition.

Depression and anxiety may reduce the likelihood of remission in patients with rheumatoid arthritis and in patients with psoriatic arthritis, according to a recently published study.

With each passing year, big data has taken on a larger role in medicine and more specifically, in rheumatology.

Let me introduce this cautiously entitled Editorial by first expressing how pleased we are to have engaged such a talented and productive group of experts on the use of “big data” in rheumatology. I am wholeheartedly enthusiastic about what we have already reaped from big data and firmly believe the greatest potential for gain in terms of research and care lie ahead.

Novartis has reported positive 5-year efficacy and safety results for Cosentyx from a phase 3 long-term extension study in patients with moderate-to-severe plaque psoriasis.

Janssen Biotech announced that the FDA has approved Tremfya for treating adults with moderate-to-severe psoriasis who are candidates for systemic therapy or phototherapy.

Among patients with psoriatic arthritis, abatacept was associated with a decrease in regulatory T-cell expression, according to a recently published study.

Researchers have published a 2017 update of treatments to target for patients with axial spondyloarthritis, peripheral spondyloarthritis and psoriatic arthritis.

MADRID — Patients with rheumatoid arthritis and psoriatic arthritis appear to have similar mental health-related quality of life as assessed by the SF-36 mental component summary, while patients with psoriatic arthritis have slightly worse physical health-related quality of life as indicated by the SF-36 physical component summary, according to a study presented at the EULAR Annual Congress.

The FDA has approved Orencia for the treatment of patients with active psoriatic arthritis. It is approved for both subcutaneous and intravenous injections, according to a company press release.